
No. of Pages: 153 | Report Code: TIPRE00022177 | Category: Life Sciences
No. of Pages: 153 | Report Code: TIPRE00022177 | Category: Life Sciences
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2.1 Key Insights
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4.1 Market Drivers
4.1.1 Increasing Applications of Protein Expression Systems
4.1.2 Surging Popularity of Precision Medicine
4.2 Market Restraints
4.2.1 High Cost of Products
4.3 Market Opportunities
4.3.1 Plant-Based Expression Systems for Therapeutic Protein Production
4.4 Future Trends
4.4.1 Integration of Artificial Intelligence (AI) and Automation Technologies
4.5 Impact of Drivers and Restraints:
5.1 Europe Transient Protein Expression Market Revenue (US$ Million), 2021–2031
5.2 Europe Transient Protein Expression Market Forecast Analysis
6.1 Instruments
6.1.1 Overview
6.1.2 Instruments: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
6.2 Reagents
6.2.1 Overview
6.2.2 Reagents: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Expression Vectors
6.3.1 Overview
6.3.2 Expression Vectors: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
6.4 Competent Cells
6.4.1 Overview
6.4.2 Competent Cells: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
7.1 Genomic Research
7.1.1 Overview
7.1.2 Genomic Research: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
7.2.1 Overview
7.2.2 Gene Therapy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Bio production
7.3.1 Overview
7.3.2 Bio production: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Cancer Research
7.4.1 Overview
7.4.2 Cancer Research: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Drug Development
7.5.1 Overview
7.5.2 Drug Development: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Overview
8.1.2 Pharmaceutical and Biotechnology Companies: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Academic and Research Institutes
8.2.1 Overview
8.2.2 Academic and Research Institutes: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Research Organizations
8.3.1 Overview
8.3.2 Clinical Research Organizations: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
9.1 Europe
9.1.1 Europe Transient Protein Expression Market Overview
9.1.2 Europe Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
9.1.2.1 Europe Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
9.1.2.2 Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.2.1 Germany: Europe Transient Protein Expression Market Breakdown, by Product Type
9.1.2.2.2 Germany: Europe Transient Protein Expression Market Breakdown, by Application
9.1.2.2.3 Germany: Europe Transient Protein Expression Market Breakdown, by End User
9.1.2.3 United Kingdom: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.3.1 United Kingdom: Europe Transient Protein Expression Market Breakdown, by Product Type
9.1.2.3.2 United Kingdom: Europe Transient Protein Expression Market Breakdown, by Application
9.1.2.3.3 United Kingdom: Europe Transient Protein Expression Market Breakdown, by End User
9.1.2.4 France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.4.1 France: Europe Transient Protein Expression Market Breakdown, by Product Type
9.1.2.4.2 France: Europe Transient Protein Expression Market Breakdown, by Application
9.1.2.4.3 France: Europe Transient Protein Expression Market Breakdown, by End User
9.1.2.5 Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.5.1 Italy: Europe Transient Protein Expression Market Breakdown, by Product Type
9.1.2.5.2 Italy: Europe Transient Protein Expression Market Breakdown, by Application
9.1.2.5.3 Italy: Europe Transient Protein Expression Market Breakdown, by End User
9.1.2.6 Spain: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.6.1 Spain: Europe Transient Protein Expression Market Breakdown, by Product Type
9.1.2.6.2 Spain: Europe Transient Protein Expression Market Breakdown, by Application
9.1.2.6.3 Spain: Europe Transient Protein Expression Market Breakdown, by End User
9.1.2.7 Rest of Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.7.1 Rest of Europe Transient Protein Expression Market Breakdown, by Product Type
9.1.2.7.2 Rest of Europe Transient Protein Expression Market Breakdown, by Application
9.1.2.7.3 Rest of Europe Transient Protein Expression Market Breakdown, by End User
10.1 Company Positioning & Concentration
11.1 Overview
11.2 Growth Strategies in Europe Transient Protein Expression Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merck KGaA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN NV
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 GenScript Biotech Corporation
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Promega Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Takara Bio Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 New England Biolabs
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Agilent Technologies Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Mirus Bio LLC
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Bio-Rad Laboratories Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Lonza Group AG
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 MaxCyte Inc
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
13.1 About The Insight Partners
13.2 Glossary of Terms
Table 1. Europe Transient Protein Expression Market Segmentation
Table 2. Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 4. Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 6. Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 7. Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 8. Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 9. Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 10. United Kingdom: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 11. United Kingdom: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 12. United Kingdom: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 13. France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 14. France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 15. France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 16. Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 17. Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 18. Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 19. Spain: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 20. Spain: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 21. Spain: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 22. Rest of Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 23. Rest of Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 24. Rest of Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 25. Recent Organic Growth Strategies in Europe Transient Protein Expression Market
Table 26. Recent Inorganic Growth Strategies in the Europe Transient Protein Expression Market
Table 27. Glossary of Terms, Transiaent Protein Expression Market
Figure 1. Europe Transient Protein Expression Market Segmentation, by Country
Figure 2. Europe Transient Protein Expression Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Transient Protein Expression Market Revenue (US$ Million), 2021–2031
Figure 5. Europe Transient Protein Expression Market Share (%) – by Product Type (2023 and 2031)
Figure 6. Instruments: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Reagents: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Expression Vectors: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Competent Cells: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Europe Transient Protein Expression Market Share (%) – by Application (2023 and 2031)
Figure 11. Genomic Research: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Gene Therapy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Bio production: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cancer Research: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Drug Development: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Europe Transient Protein Expression Market Share (%) – by End User (2023 and 2031)
Figure 17. Pharmaceutical and Biotechnology Companies: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Academic and Research Institutes: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Clinical Research Organizations: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Europe Transient Protein Expression Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)
Figure 21. Europe Transient Protein Expression Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 22. Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 23. United Kingdom: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 24. France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 25. Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 26. Spain: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. Rest of Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. Company Positioning & Concentration
Figure 29. Growth Strategies in Europe Transient Protein Expression Market